Reyes C, Chang L K, Waffarn F, Mir H, Warden M J, Sills J
Department of Surgery, University of California, Irvine Medical Center, Orange 92868, USA.
J Pediatr Surg. 1998 Jul;33(7):1010-4; discussion 1014-6. doi: 10.1016/s0022-3468(98)90523-1.
The authors reviewed their experience in the management of CDH after the introduction of early high-frequency oscillatory ventilation (HFOV) during the preoperative stabilization period and delayed CDH repair.
This is a retrospective analysis of 24 consecutive infants with CDH treated at University of California, Irvine Medical Center (UCIMC) during a 36-month period from January 1993 to December 1996.
Two patients were excluded from the study: one fetus with a prenatal diagnosis was referred for fetal surgery; one infant received CDH repair at another institution 2 weeks before transfer to UCIMC. Eight (36%) infants were inborn, and nine (41%) had a prenatal diagnosis of CDH. Median gestational age was 40 weeks (range, 29 to 42 weeks). Median birth weight was 3,019 g (range, 1,205 to 4,337 g). The defect was left sided in 18 infants (86%). Twenty-one infants were intubated within 5 hours of life, 15 had an AaDO2 greater than 610, 11 had an oxygenation index greater than 40, and 11 had a pH of less than 7.2. The median ratio of pulmonary artery pressure to systemic blood pressure was 0.93 (range, 0.51 to 1.15) in 12 infants. Eighteen infants were placed on HFOV within a median of 1 hour of life. Nitric oxide was given to six infants and surfactant to eight. Four infants were referred for extracorporeal membrane oxygenation (ECMO). Repair of CDH was performed on infants at a median age of 33.5 hours (range, 5.5 to 322). Six (30%) received a prosthetic patch. Overall 18 of 22 infants survived (81%); three survivors received ECMO. Two infants of the survivor group had congenital heart anomalies: one ventricular septal defect (VSD) and one double-outlet right ventricle with a VSD. Of the four nonsurvivors, one had lethal cardiac anomalies and bilateral CDH, two had severe bilateral pulmonary hypoplasia (one received ECMO), and one infant was a 29-week premature baby who did not qualify for ECMO.
We report a survival rate of 81% (18 of 22) with the management of CDH by delayed surgical repair, early postnatal HFOV, and selective referral for ECMO.
作者回顾了在术前稳定期引入早期高频振荡通气(HFOV)及延迟先天性膈疝(CDH)修复术后,他们在CDH管理方面的经验。
这是一项对1993年1月至1996年12月期间在加利福尼亚大学欧文医学中心(UCIMC)接受治疗的24例连续CDH婴儿的回顾性分析。
两名患者被排除在研究之外:一名产前诊断为胎儿的胎儿被转诊进行胎儿手术;一名婴儿在转至UCIMC前2周在另一机构接受了CDH修复。8例(36%)婴儿为足月儿,9例(41%)产前诊断为CDH。中位胎龄为40周(范围29至42周)。中位出生体重为3019克(范围1205至4337克)。18例婴儿(86%)的缺损位于左侧。21例婴儿在出生后5小时内插管,15例的肺泡动脉氧分压差(AaDO2)大于610,11例的氧合指数大于40,11例的pH值小于7.2。12例婴儿的肺动脉压与体循环血压的中位比值为0.93(范围0.51至1.15)。18例婴儿在出生后中位1小时内开始接受HFOV治疗。6例婴儿给予一氧化氮,8例给予表面活性剂。4例婴儿被转诊接受体外膜肺氧合(ECMO)治疗。CDH修复手术在婴儿中位年龄33.5小时(范围5.5至322小时)时进行。6例(30%)接受了人工补片。总体而言,22例婴儿中有18例存活(81%);3例存活者接受了ECMO治疗。存活组中的2例婴儿有先天性心脏异常:1例室间隔缺损(VSD),1例右心室双出口合并VSD。在4例非存活者中,1例有致命性心脏异常和双侧CDH,2例有严重双侧肺发育不全(1例接受了ECMO治疗),1例婴儿是29周早产儿,不符合ECMO治疗条件。
我们报告了通过延迟手术修复、出生后早期HFOV及选择性转诊接受ECMO治疗CDH的存活率为81%(22例中的18例)。